Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
89.22%
Operating Margin
87.32%
Net Margin
90.08%
Efficiency Metrics
Revenue per Expense Ratio
7.89
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
98.53%
Income Tax Rate
2.38%
EPS
1.7100000000
Balance Sheet Analysis
Current Ratio
2.46
Cash Ratio
1.65
Working Capital
$5.74M
Debt to Equity
0.13
Debt to Assets
11.33%
Equity Ratio
85.77%
Cash Flow Analysis
Operating Cash Flow Ratio
86.03%
Free Cash Flow Ratio
86.03%
CapEx to Revenue
0.00%
Dividends Paid
$12.51M
Stock Buybacks
No buybacks
Total Shareholder Returns
$12.51M
Cash Position Change
32.84%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 43.90%
Detailed Growth Metrics
Core Performance
Revenue
143.45%
Net Income
160.31%
EPS
159.09%
Operating Income
110.33%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
176.04%
Operating Cash Flow
2,964.36%
Free Cash Flow
2,964.36%
Balance Sheet Health
Assets
2.34%
Debt
-8.20%
Book Value per Share
2.80%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
43.90%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
185.67%
5Y Revenue/Share
328.43%
3Y Dividend/Share
35.69%
5Y Dividend/Share
8.36%